Navigation Links
Medivation Reports Fourth Quarter and Year-End 2008 Financial Results and Provides Corporate Update
Date:3/16/2009

we and Pfizer elect to pursue that option.
  • Plan to initiate enrollment next month in our Phase 3 CONCERT trial, a 12-month safety and efficacy study evaluating Dimebon in combination with donepezil (Aricept(R)) in approximately 1,000 patients with mild-to-moderate Alzheimer's disease.
  • Plan to initiate two additional Phase 3 studies in 2009 that will evaluate Dimebon in a total of approximately 1,100 patients with moderate-to-severe Alzheimer's disease.
  • Huntington's Disease

    • Held an end-of-Phase 2 meeting at which the U.S. Food and Drug Administration (FDA) informed us that we could begin a Phase 3 trial of Dimebon in patients with Huntington's disease using the Mini-Mental State Examination (MMSE) and the Clinician's Interview-based Impression of Change, plus caregiver input (CIBIC-plus) as co-primary endpoints. Discussions with the European regulators are ongoing. We expect to begin this study in 2009.
    • Presented the data from the Phase 2 trial of Dimebon in Huntington's disease patients at the 9th International Conference on Alzheimer's and Parkinson's Diseases (AD/PD) held last week. Results showed Dimebon to be well tolerated and to significantly improve cognition as measured by the MMSE.

    Mechanism of Action (MOA)

    • Presented new data at various medical conferences, including the recent AD/PD conference, that provide additional evidence that Dimebon potentially stabilizes and improves mitochondrial function in a way that prevents neuron death and dysfunction, a mechanism thought to be distinct from currently available Alzheimer's disease medications.
    • At AD/PD, we presented new research from the Karolinska Institutet, which quantified the impact of Dimebon on mitochondrial function. Responses were seen on mitochondria
      '/>"/>

    SOURCE Medivation, Inc.
    Copyright©2009 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8

    Related biology technology :

    1. Medivation Announces New Positive Efficacy Data From Phase 1-2 Trial of MDV3100 in Castration-Resistant Prostate Cancer Patients
    2. Medivation Presents New Data on Dimebons Novel Mechanism of Action
    3. Medivation Announces Participation in RBC Capital Markets 2008 Healthcare Conference
    4. Medivation Reports Third Quarter 2008 Financial Results and Provides Corporate Update
    5. Medivation Announces Third Quarter 2008 Teleconference and Webcast on November 10, 2008
    6. Medivation Announces Expiration of Hart-Scott-Rodino Waiting Period for Collaboration With Pfizer
    7. Medivation Announces Presentation of 24-Week Clinical Data of MDV3100 in Castration-Resistant Prostate Cancer Patients
    8. Medivation Receives Corporate Achievement Award From Huntingtons Disease Society of America
    9. Medivation to Host Conference Call at 8:30 a.m. Eastern Time Tomorrow to Discuss Partnering Plans for Dimebon
    10. Medivation Announces Participation in Upcoming Conferences
    11. Medivation Reports Second Quarter 2008 Financial Results and Provides Corporate Update
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:5/29/2015)... (PRWEB) May 29, 2015 Market ... (Chem-Report ) signed a partnership agreement for quality ... authorised to distribute and sell research reports worked ... at Partners Department, commented upon the agreement: “Chem-Report ... on key petroleum and chemical markets on global ...
    (Date:5/29/2015)...  Caris Life Sciences ® , a leading ... precision medicine, today announced the presentation of data ... of Caris Molecular Intelligence ® , the company,s ... identify targeted treatment options for patients with rare ... results of which are to be presented in ...
    (Date:5/29/2015)... (PRWEB) May 29, 2015 Seoul ... leader in LED technology, on May 28th announced ... market share by strengthening its high efficient and ... application , Since 2011 Seoul Semiconductor has developed ... lighting market and has supplied LEDs for headlamps ...
    (Date:5/28/2015)... MADISON, N.J. , May 28, 2015  Quest ... provider of diagnostic information services, announced that it is ... Conference in New York.  Steve Rusckowski , the ... goals and five point strategy.  The presentation is scheduled ... Time. The presentation will be webcast live ...
    Breaking Biology Technology:Market Publishers Ltd and Chem-Report Sign Partnership Agreement 2Market Publishers Ltd and Chem-Report Sign Partnership Agreement 3Multi-Platform Tumor Profiling from Caris Life Sciences Identifies Targeted Treatment Options for Patients with Rare and/or Aggressive Tumors 2Multi-Platform Tumor Profiling from Caris Life Sciences Identifies Targeted Treatment Options for Patients with Rare and/or Aggressive Tumors 3Multi-Platform Tumor Profiling from Caris Life Sciences Identifies Targeted Treatment Options for Patients with Rare and/or Aggressive Tumors 4Multi-Platform Tumor Profiling from Caris Life Sciences Identifies Targeted Treatment Options for Patients with Rare and/or Aggressive Tumors 5Multi-Platform Tumor Profiling from Caris Life Sciences Identifies Targeted Treatment Options for Patients with Rare and/or Aggressive Tumors 6Seoul Semiconductor Increases the Global Automotive LED Market Share with its High Efficient and Reliable LEDs for Automotive Lightings 2Quest Diagnostics to Speak at the Jefferies 2015 Global Healthcare Conference 2
    ... is squarely in front of the nation again, and myriads of ... these opinions, we see they are driven by an almost equal ... used in this debate. , ,A recent article ... us a good example to use to examine one small part ...
    ... University of Wisconsin-Madison faculty members Sean Carroll ... to the National Academy of Sciences . , ... most prestigious honors bestowed upon American scientists. Carroll, a ... professor of chemistry and biochemistry, were recognized for distinguished ...
    ... has become an important force in Wisconsin's economy because ... through discovery and research, the 30,000 skilled people it ... the nearly $8 billion in revenue generated by bioscience ... have positioned themselves as national and international leaders in ...
    Cached Biology Technology:Misconceptions dominate the immigration debate 2Misconceptions dominate the immigration debate 3Misconceptions dominate the immigration debate 4Misconceptions dominate the immigration debate 5Wisconsin biosciences rise to the challenge 2Wisconsin biosciences rise to the challenge 3
    (Date:4/27/2015)... 27, 2015  For more than four decades, AUVSI,s ... been the premier worldwide event for the unmanned land, ... must-attend event for any local, national, or trade news ... commercial markets and current applications of unmanned technologies. The ... projected $48 billion industry, and how it will soon ...
    (Date:4/20/2015)... DUBAI , April 20, 2015 ... soars   Glenbeigh Records Management (GRM), ... contract with Dubai Islamic Bank. Having built up an impressive ... is now a leading player within the records management sector ... company expects to double is GCC staffbase and employ a ...
    (Date:4/13/2015)... CHICAGO , April 13, 2015  higi, a ... with ways to more fully engage with their communities ... its industry-leading, privacy protected and secure API.  ... API enables the most accessible, affordable, and convenient vehicle ... The API will ...
    Breaking Biology News(10 mins):UNMANNED SYSTEMS 2015: Largest International Conference and Trade Show for the Drone and Unmanned Technology Industry 2UNMANNED SYSTEMS 2015: Largest International Conference and Trade Show for the Drone and Unmanned Technology Industry 3UNMANNED SYSTEMS 2015: Largest International Conference and Trade Show for the Drone and Unmanned Technology Industry 4UNMANNED SYSTEMS 2015: Largest International Conference and Trade Show for the Drone and Unmanned Technology Industry 5Glenbeigh Records Management Wins Contract With Dubai Islamic Bank 2Glenbeigh Records Management Wins Contract With Dubai Islamic Bank 3higi Launches Seamless Access to HIPAA-Compliant Health Outcomes and Activity Data 2higi Launches Seamless Access to HIPAA-Compliant Health Outcomes and Activity Data 3
    ... city dwellers posed by Southern California wildfires like ... by officials. Detailed particulate analysis of the ... that the composition posed more serious potential threats ... a new paper analyzing particulate matter (PM) from ...
    ... jellyfish - have the simplest eyes that exist. They ... cell and a pigment cell. These minimal eyes, called ... the first eyes to appear in animal evolution. They ... the direction of light. This ability is crucial for ...
    ... Scientists at St. Jude Children,s Research Hospital have gained ... enzyme workhorses called calpains. As the cell,s ... the movement of cells in tissues, the death of ... function. The downside of this broad set of responsibilities ...
    Cached Biology News:Where there's wildfire smoke, there's toxicity 2Uncovering secrets of life in the ocean 2New insight into the controls on a go-to enzyme 2New insight into the controls on a go-to enzyme 3
    ... Scalable SNPstream System Delivers 4,600 to ... GenomeLab SNPstream Genotyping System is capable of ... per day. Part of the GenomeLab family ... can process up to 48 SNPs in ...
    ... White to off-white solid. A ... and blocks the formation of N-glycosidic ... against Gram-positive bacteria, yeasts, fungi, ... functional thrombin receptors on human T-lymphoblastoid ...
    ... 220 V, is used for agitation and mixing ... staining and destaining of gels and blots, and ... (8-40 rpm) and can handle a maximum load ... two 29 x 21 cm platforms covered with ...
    ...
    Biology Products: